| Basics |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
|
| IPO Date: |
April 2, 1991 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$60.77B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$4.26 | 1.80%
|
| Avg Daily Range (30 D): |
$7.84 | 1.36%
|
| Avg Daily Range (90 D): |
$8.31 | 1.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.66M |
| Avg Daily Volume (30 D): |
.77M |
| Avg Daily Volume (90 D): |
.97M |
| Trade Size |
| Avg Trade Size (Sh.): |
63 |
| Avg Trade Size (Sh.) (30 D): |
26 |
| Avg Trade Size (Sh.) (90 D): |
28 |
| Institutional Trades |
| Total Inst.Trades: |
11,244 |
| Avg Inst. Trade: |
$18.39M |
| Avg Inst. Trade (30 D): |
$46.49M |
| Avg Inst. Trade (90 D): |
$37.79M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$36.11M |
| Avg Closing Trade (30 D): |
$75.14M |
| Avg Closing Trade (90 D): |
$81.4M |
| Avg Closing Volume: |
73.31K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$41.76
|
$13.24
|
$7.58
|
|
Diluted EPS
|
$39.73
|
$12.81
|
$7.27
|
|
Revenue
|
$ 14.21B
|
$ 3.68B
|
$ 3.03B
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ 4.46B
|
$ 1.39B
|
$ 808.7M
|
|
Operating Income / Loss
|
$ 3.84B
|
$ 1.08B
|
$ 591.7M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 87.4M
|
$ -1077.4M
|
$ 604M
|
|
PE Ratio
|
13.95
|
|
|
|
|
|
